Faruqi & Faruqi, LLP Launches An Investigation Against Dolby Laboratories, Inc. (DLB) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Dolby Laboratories Inc. (“Dolby” or the “Company”) (NYSE: DLB) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders’ approval for the amendment and restatement of the Company’s 2005 Stock Plan.
Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on December 26, 2012, the Board of Directors recommends that Dolby’s shareholders vote to approve the amendment and restatement of the Company’s 2005 Stock Plan to reserve an additional 8,000,000 shares of Class A Common Stock for issuance thereunder. Dolby’s Board of Directors also recommends that shareholders vote for a proposal to amend and restate the Company’s Employee Stock Purchase Plan to reserve an additional 3,000,000 shares of Class A Common Stock for purchase thereunder. The issuance of the additional shares could have a substantial dilutive effect on the shares of Dolby’s common stock.
If you own common stock in Dolby and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330.
Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.